A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)

NCT06561074 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

T-cell Acute Lymphoblastic Leukemia
T-Cell Lymphoblastic Lymphoma

Interventions

DRUG: Decitabine
DRUG: Venetoclax
DRUG: Calaspargase pegol-mknl

Sponsor

M.D. Anderson Cancer Center